Cancer Tumor Profiling Market - Global Outlook and Forecast 2022-2028
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
This report contains market size and forecasts of Cancer Tumor Profiling in Global, including the following market information:
Global Cancer Tumor Profiling Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Tumor Profiling market was valued at 40550 million in 2021 and is projected to reach US$ 78790 million by 2028, at a CAGR of 10.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Next-generation Sequencing (NGS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Tumor Profiling include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., NeoGenomics Laboratories, HTG Molecular Diagnostic, Genomic Health Inc., Hologic Gen-Probe and BD Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Tumor Profiling companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Tumor Profiling Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Tumor Profiling Market Segment Percentages, by Type, 2021 (%)
Global Cancer Tumor Profiling Market Segment Percentages, by Application, 2021 (%)
Global Cancer Tumor Profiling Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Cancer Tumor Profiling revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Tumor Profiling revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Cancer Tumor Profiling in Global, including the following market information:
Global Cancer Tumor Profiling Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Tumor Profiling market was valued at 40550 million in 2021 and is projected to reach US$ 78790 million by 2028, at a CAGR of 10.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Next-generation Sequencing (NGS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Tumor Profiling include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., NeoGenomics Laboratories, HTG Molecular Diagnostic, Genomic Health Inc., Hologic Gen-Probe and BD Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Tumor Profiling companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Tumor Profiling Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Tumor Profiling Market Segment Percentages, by Type, 2021 (%)
- Next-generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Microarray
- Others
Global Cancer Tumor Profiling Market Segment Percentages, by Application, 2021 (%)
- Personalized Medicine
- Diagnostics
- Biomarker Discovery
- Prognostics
- Research Applications
Global Cancer Tumor Profiling Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Cancer Tumor Profiling revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Tumor Profiling revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Qiagen N.V.
- Roche Molecular Systems Inc.
- Abott Molecular
- Illumina Inc.
- NeoGenomics Laboratories
- HTG Molecular Diagnostic
- Genomic Health Inc.
- Hologic Gen-Probe
- BD Biosciences
- Siemens Healthineers
- Claris Life Sciences
- Personal Genome Diagnostics, Inc.
- Perthera, Inc.
- Foundation Medicine, Inc
- V., Strand
- ApoCell
- Contextual Genomics
- Agendia
- GenScript
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Cancer Tumor Profiling Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Tumor Profiling Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CANCER TUMOR PROFILING OVERALL MARKET SIZE
2.1 Global Cancer Tumor Profiling Market Size: 2021 VS 2028
2.2 Global Cancer Tumor Profiling Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Cancer Tumor Profiling Players in Global Market
3.2 Top Global Cancer Tumor Profiling Companies Ranked by Revenue
3.3 Global Cancer Tumor Profiling Revenue by Companies
3.4 Top 3 and Top 5 Cancer Tumor Profiling Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Tumor Profiling Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Tumor Profiling Players in Global Market
3.6.1 List of Global Tier 1 Cancer Tumor Profiling Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Tumor Profiling Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Cancer Tumor Profiling Market Size Markets, 2021 & 2028
4.1.2 Next-generation Sequencing (NGS)
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Immunohistochemistry (IHC)
4.1.5 In Situ Hybridization (ISH)
4.1.6 Microarray
4.1.7 Others
4.2 By Type - Global Cancer Tumor Profiling Revenue & Forecasts
4.2.1 By Type - Global Cancer Tumor Profiling Revenue, 2017-2022
4.2.2 By Type - Global Cancer Tumor Profiling Revenue, 2023-2028
4.2.3 By Type - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cancer Tumor Profiling Market Size, 2021 & 2028
5.1.2 Personalized Medicine
5.1.3 Diagnostics
5.1.4 Biomarker Discovery
5.1.5 Prognostics
5.1.6 Research Applications
5.2 By Application - Global Cancer Tumor Profiling Revenue & Forecasts
5.2.1 By Application - Global Cancer Tumor Profiling Revenue, 2017-2022
5.2.2 By Application - Global Cancer Tumor Profiling Revenue, 2023-2028
5.2.3 By Application - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cancer Tumor Profiling Market Size, 2021 & 2028
6.2 By Region - Global Cancer Tumor Profiling Revenue & Forecasts
6.2.1 By Region - Global Cancer Tumor Profiling Revenue, 2017-2022
6.2.2 By Region - Global Cancer Tumor Profiling Revenue, 2023-2028
6.2.3 By Region - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Tumor Profiling Revenue, 2017-2028
6.3.2 US Cancer Tumor Profiling Market Size, 2017-2028
6.3.3 Canada Cancer Tumor Profiling Market Size, 2017-2028
6.3.4 Mexico Cancer Tumor Profiling Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Tumor Profiling Revenue, 2017-2028
6.4.2 Germany Cancer Tumor Profiling Market Size, 2017-2028
6.4.3 France Cancer Tumor Profiling Market Size, 2017-2028
6.4.4 U.K. Cancer Tumor Profiling Market Size, 2017-2028
6.4.5 Italy Cancer Tumor Profiling Market Size, 2017-2028
6.4.6 Russia Cancer Tumor Profiling Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Tumor Profiling Market Size, 2017-2028
6.4.8 Benelux Cancer Tumor Profiling Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Tumor Profiling Revenue, 2017-2028
6.5.2 China Cancer Tumor Profiling Market Size, 2017-2028
6.5.3 Japan Cancer Tumor Profiling Market Size, 2017-2028
6.5.4 South Korea Cancer Tumor Profiling Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Tumor Profiling Market Size, 2017-2028
6.5.6 India Cancer Tumor Profiling Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Tumor Profiling Revenue, 2017-2028
6.6.2 Brazil Cancer Tumor Profiling Market Size, 2017-2028
6.6.3 Argentina Cancer Tumor Profiling Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Tumor Profiling Revenue, 2017-2028
6.7.2 Turkey Cancer Tumor Profiling Market Size, 2017-2028
6.7.3 Israel Cancer Tumor Profiling Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Tumor Profiling Market Size, 2017-2028
6.7.5 UAE Cancer Tumor Profiling Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Corporate Summary
7.1.2 Qiagen N.V. Business Overview
7.1.3 Qiagen N.V. Cancer Tumor Profiling Major Product Offerings
7.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.1.5 Qiagen N.V. Key News
7.2 Roche Molecular Systems Inc.
7.2.1 Roche Molecular Systems Inc. Corporate Summary
7.2.2 Roche Molecular Systems Inc. Business Overview
7.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Major Product Offerings
7.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.2.5 Roche Molecular Systems Inc. Key News
7.3 Abott Molecular
7.3.1 Abott Molecular Corporate Summary
7.3.2 Abott Molecular Business Overview
7.3.3 Abott Molecular Cancer Tumor Profiling Major Product Offerings
7.3.4 Abott Molecular Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.3.5 Abott Molecular Key News
7.4 Illumina Inc.
7.4.1 Illumina Inc. Corporate Summary
7.4.2 Illumina Inc. Business Overview
7.4.3 Illumina Inc. Cancer Tumor Profiling Major Product Offerings
7.4.4 Illumina Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.4.5 Illumina Inc. Key News
7.5 NeoGenomics Laboratories
7.5.1 NeoGenomics Laboratories Corporate Summary
7.5.2 NeoGenomics Laboratories Business Overview
7.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Major Product Offerings
7.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.5.5 NeoGenomics Laboratories Key News
7.6 HTG Molecular Diagnostic
7.6.1 HTG Molecular Diagnostic Corporate Summary
7.6.2 HTG Molecular Diagnostic Business Overview
7.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Major Product Offerings
7.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.6.5 HTG Molecular Diagnostic Key News
7.7 Genomic Health Inc.
7.7.1 Genomic Health Inc. Corporate Summary
7.7.2 Genomic Health Inc. Business Overview
7.7.3 Genomic Health Inc. Cancer Tumor Profiling Major Product Offerings
7.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.7.5 Genomic Health Inc. Key News
7.8 Hologic Gen-Probe
7.8.1 Hologic Gen-Probe Corporate Summary
7.8.2 Hologic Gen-Probe Business Overview
7.8.3 Hologic Gen-Probe Cancer Tumor Profiling Major Product Offerings
7.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.8.5 Hologic Gen-Probe Key News
7.9 BD Biosciences
7.9.1 BD Biosciences Corporate Summary
7.9.2 BD Biosciences Business Overview
7.9.3 BD Biosciences Cancer Tumor Profiling Major Product Offerings
7.9.4 BD Biosciences Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.9.5 BD Biosciences Key News
7.10 Siemens Healthineers
7.10.1 Siemens Healthineers Corporate Summary
7.10.2 Siemens Healthineers Business Overview
7.10.3 Siemens Healthineers Cancer Tumor Profiling Major Product Offerings
7.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.10.5 Siemens Healthineers Key News
7.11 Claris Life Sciences
7.11.1 Claris Life Sciences Corporate Summary
7.11.2 Claris Life Sciences Business Overview
7.11.3 Claris Life Sciences Cancer Tumor Profiling Major Product Offerings
7.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.11.5 Claris Life Sciences Key News
7.12 Personal Genome Diagnostics, Inc.
7.12.1 Personal Genome Diagnostics, Inc. Corporate Summary
7.12.2 Personal Genome Diagnostics, Inc. Business Overview
7.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Major Product Offerings
7.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.12.5 Personal Genome Diagnostics, Inc. Key News
7.13 Perthera, Inc.
7.13.1 Perthera, Inc. Corporate Summary
7.13.2 Perthera, Inc. Business Overview
7.13.3 Perthera, Inc. Cancer Tumor Profiling Major Product Offerings
7.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.13.5 Perthera, Inc. Key News
7.14 Foundation Medicine, Inc
7.14.1 Foundation Medicine, Inc Corporate Summary
7.14.2 Foundation Medicine, Inc Business Overview
7.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Major Product Offerings
7.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.14.5 Foundation Medicine, Inc Key News
7.15 V., Strand
7.15.1 V., Strand Corporate Summary
7.15.2 V., Strand Business Overview
7.15.3 V., Strand Cancer Tumor Profiling Major Product Offerings
7.15.4 V., Strand Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.15.5 V., Strand Key News
7.16 ApoCell
7.16.1 ApoCell Corporate Summary
7.16.2 ApoCell Business Overview
7.16.3 ApoCell Cancer Tumor Profiling Major Product Offerings
7.16.4 ApoCell Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.16.5 ApoCell Key News
7.17 Contextual Genomics
7.17.1 Contextual Genomics Corporate Summary
7.17.2 Contextual Genomics Business Overview
7.17.3 Contextual Genomics Cancer Tumor Profiling Major Product Offerings
7.17.4 Contextual Genomics Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.17.5 Contextual Genomics Key News
7.18 Agendia
7.18.1 Agendia Corporate Summary
7.18.2 Agendia Business Overview
7.18.3 Agendia Cancer Tumor Profiling Major Product Offerings
7.18.4 Agendia Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.18.5 Agendia Key News
7.19 GenScript
7.19.1 GenScript Corporate Summary
7.19.2 GenScript Business Overview
7.19.3 GenScript Cancer Tumor Profiling Major Product Offerings
7.19.4 GenScript Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.19.5 GenScript Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Cancer Tumor Profiling Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Tumor Profiling Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CANCER TUMOR PROFILING OVERALL MARKET SIZE
2.1 Global Cancer Tumor Profiling Market Size: 2021 VS 2028
2.2 Global Cancer Tumor Profiling Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Cancer Tumor Profiling Players in Global Market
3.2 Top Global Cancer Tumor Profiling Companies Ranked by Revenue
3.3 Global Cancer Tumor Profiling Revenue by Companies
3.4 Top 3 and Top 5 Cancer Tumor Profiling Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Tumor Profiling Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Tumor Profiling Players in Global Market
3.6.1 List of Global Tier 1 Cancer Tumor Profiling Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Tumor Profiling Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Cancer Tumor Profiling Market Size Markets, 2021 & 2028
4.1.2 Next-generation Sequencing (NGS)
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Immunohistochemistry (IHC)
4.1.5 In Situ Hybridization (ISH)
4.1.6 Microarray
4.1.7 Others
4.2 By Type - Global Cancer Tumor Profiling Revenue & Forecasts
4.2.1 By Type - Global Cancer Tumor Profiling Revenue, 2017-2022
4.2.2 By Type - Global Cancer Tumor Profiling Revenue, 2023-2028
4.2.3 By Type - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cancer Tumor Profiling Market Size, 2021 & 2028
5.1.2 Personalized Medicine
5.1.3 Diagnostics
5.1.4 Biomarker Discovery
5.1.5 Prognostics
5.1.6 Research Applications
5.2 By Application - Global Cancer Tumor Profiling Revenue & Forecasts
5.2.1 By Application - Global Cancer Tumor Profiling Revenue, 2017-2022
5.2.2 By Application - Global Cancer Tumor Profiling Revenue, 2023-2028
5.2.3 By Application - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cancer Tumor Profiling Market Size, 2021 & 2028
6.2 By Region - Global Cancer Tumor Profiling Revenue & Forecasts
6.2.1 By Region - Global Cancer Tumor Profiling Revenue, 2017-2022
6.2.2 By Region - Global Cancer Tumor Profiling Revenue, 2023-2028
6.2.3 By Region - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Tumor Profiling Revenue, 2017-2028
6.3.2 US Cancer Tumor Profiling Market Size, 2017-2028
6.3.3 Canada Cancer Tumor Profiling Market Size, 2017-2028
6.3.4 Mexico Cancer Tumor Profiling Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Tumor Profiling Revenue, 2017-2028
6.4.2 Germany Cancer Tumor Profiling Market Size, 2017-2028
6.4.3 France Cancer Tumor Profiling Market Size, 2017-2028
6.4.4 U.K. Cancer Tumor Profiling Market Size, 2017-2028
6.4.5 Italy Cancer Tumor Profiling Market Size, 2017-2028
6.4.6 Russia Cancer Tumor Profiling Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Tumor Profiling Market Size, 2017-2028
6.4.8 Benelux Cancer Tumor Profiling Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Tumor Profiling Revenue, 2017-2028
6.5.2 China Cancer Tumor Profiling Market Size, 2017-2028
6.5.3 Japan Cancer Tumor Profiling Market Size, 2017-2028
6.5.4 South Korea Cancer Tumor Profiling Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Tumor Profiling Market Size, 2017-2028
6.5.6 India Cancer Tumor Profiling Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Tumor Profiling Revenue, 2017-2028
6.6.2 Brazil Cancer Tumor Profiling Market Size, 2017-2028
6.6.3 Argentina Cancer Tumor Profiling Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Tumor Profiling Revenue, 2017-2028
6.7.2 Turkey Cancer Tumor Profiling Market Size, 2017-2028
6.7.3 Israel Cancer Tumor Profiling Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Tumor Profiling Market Size, 2017-2028
6.7.5 UAE Cancer Tumor Profiling Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Corporate Summary
7.1.2 Qiagen N.V. Business Overview
7.1.3 Qiagen N.V. Cancer Tumor Profiling Major Product Offerings
7.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.1.5 Qiagen N.V. Key News
7.2 Roche Molecular Systems Inc.
7.2.1 Roche Molecular Systems Inc. Corporate Summary
7.2.2 Roche Molecular Systems Inc. Business Overview
7.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Major Product Offerings
7.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.2.5 Roche Molecular Systems Inc. Key News
7.3 Abott Molecular
7.3.1 Abott Molecular Corporate Summary
7.3.2 Abott Molecular Business Overview
7.3.3 Abott Molecular Cancer Tumor Profiling Major Product Offerings
7.3.4 Abott Molecular Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.3.5 Abott Molecular Key News
7.4 Illumina Inc.
7.4.1 Illumina Inc. Corporate Summary
7.4.2 Illumina Inc. Business Overview
7.4.3 Illumina Inc. Cancer Tumor Profiling Major Product Offerings
7.4.4 Illumina Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.4.5 Illumina Inc. Key News
7.5 NeoGenomics Laboratories
7.5.1 NeoGenomics Laboratories Corporate Summary
7.5.2 NeoGenomics Laboratories Business Overview
7.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Major Product Offerings
7.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.5.5 NeoGenomics Laboratories Key News
7.6 HTG Molecular Diagnostic
7.6.1 HTG Molecular Diagnostic Corporate Summary
7.6.2 HTG Molecular Diagnostic Business Overview
7.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Major Product Offerings
7.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.6.5 HTG Molecular Diagnostic Key News
7.7 Genomic Health Inc.
7.7.1 Genomic Health Inc. Corporate Summary
7.7.2 Genomic Health Inc. Business Overview
7.7.3 Genomic Health Inc. Cancer Tumor Profiling Major Product Offerings
7.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.7.5 Genomic Health Inc. Key News
7.8 Hologic Gen-Probe
7.8.1 Hologic Gen-Probe Corporate Summary
7.8.2 Hologic Gen-Probe Business Overview
7.8.3 Hologic Gen-Probe Cancer Tumor Profiling Major Product Offerings
7.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.8.5 Hologic Gen-Probe Key News
7.9 BD Biosciences
7.9.1 BD Biosciences Corporate Summary
7.9.2 BD Biosciences Business Overview
7.9.3 BD Biosciences Cancer Tumor Profiling Major Product Offerings
7.9.4 BD Biosciences Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.9.5 BD Biosciences Key News
7.10 Siemens Healthineers
7.10.1 Siemens Healthineers Corporate Summary
7.10.2 Siemens Healthineers Business Overview
7.10.3 Siemens Healthineers Cancer Tumor Profiling Major Product Offerings
7.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.10.5 Siemens Healthineers Key News
7.11 Claris Life Sciences
7.11.1 Claris Life Sciences Corporate Summary
7.11.2 Claris Life Sciences Business Overview
7.11.3 Claris Life Sciences Cancer Tumor Profiling Major Product Offerings
7.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.11.5 Claris Life Sciences Key News
7.12 Personal Genome Diagnostics, Inc.
7.12.1 Personal Genome Diagnostics, Inc. Corporate Summary
7.12.2 Personal Genome Diagnostics, Inc. Business Overview
7.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Major Product Offerings
7.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.12.5 Personal Genome Diagnostics, Inc. Key News
7.13 Perthera, Inc.
7.13.1 Perthera, Inc. Corporate Summary
7.13.2 Perthera, Inc. Business Overview
7.13.3 Perthera, Inc. Cancer Tumor Profiling Major Product Offerings
7.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.13.5 Perthera, Inc. Key News
7.14 Foundation Medicine, Inc
7.14.1 Foundation Medicine, Inc Corporate Summary
7.14.2 Foundation Medicine, Inc Business Overview
7.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Major Product Offerings
7.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.14.5 Foundation Medicine, Inc Key News
7.15 V., Strand
7.15.1 V., Strand Corporate Summary
7.15.2 V., Strand Business Overview
7.15.3 V., Strand Cancer Tumor Profiling Major Product Offerings
7.15.4 V., Strand Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.15.5 V., Strand Key News
7.16 ApoCell
7.16.1 ApoCell Corporate Summary
7.16.2 ApoCell Business Overview
7.16.3 ApoCell Cancer Tumor Profiling Major Product Offerings
7.16.4 ApoCell Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.16.5 ApoCell Key News
7.17 Contextual Genomics
7.17.1 Contextual Genomics Corporate Summary
7.17.2 Contextual Genomics Business Overview
7.17.3 Contextual Genomics Cancer Tumor Profiling Major Product Offerings
7.17.4 Contextual Genomics Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.17.5 Contextual Genomics Key News
7.18 Agendia
7.18.1 Agendia Corporate Summary
7.18.2 Agendia Business Overview
7.18.3 Agendia Cancer Tumor Profiling Major Product Offerings
7.18.4 Agendia Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.18.5 Agendia Key News
7.19 GenScript
7.19.1 GenScript Corporate Summary
7.19.2 GenScript Business Overview
7.19.3 GenScript Cancer Tumor Profiling Major Product Offerings
7.19.4 GenScript Cancer Tumor Profiling Revenue in Global Market (2017-2022)
7.19.5 GenScript Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Cancer Tumor Profiling Market Opportunities & Trends in Global Market
Table 2. Cancer Tumor Profiling Market Drivers in Global Market
Table 3. Cancer Tumor Profiling Market Restraints in Global Market
Table 4. Key Players of Cancer Tumor Profiling in Global Market
Table 5. Top Cancer Tumor Profiling Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Tumor Profiling Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Tumor Profiling Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Tumor Profiling Product Type
Table 9. List of Global Tier 1 Cancer Tumor Profiling Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Tumor Profiling Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Tumor Profiling Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Tumor Profiling Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Tumor Profiling Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Tumor Profiling Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Tumor Profiling Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 30. Qiagen N.V. Corporate Summary
Table 31. Qiagen N.V. Cancer Tumor Profiling Product Offerings
Table 32. Qiagen N.V. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 33. Roche Molecular Systems Inc. Corporate Summary
Table 34. Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offerings
Table 35. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 36. Abott Molecular Corporate Summary
Table 37. Abott Molecular Cancer Tumor Profiling Product Offerings
Table 38. Abott Molecular Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 39. Illumina Inc. Corporate Summary
Table 40. Illumina Inc. Cancer Tumor Profiling Product Offerings
Table 41. Illumina Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 42. NeoGenomics Laboratories Corporate Summary
Table 43. NeoGenomics Laboratories Cancer Tumor Profiling Product Offerings
Table 44. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 45. HTG Molecular Diagnostic Corporate Summary
Table 46. HTG Molecular Diagnostic Cancer Tumor Profiling Product Offerings
Table 47. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 48. Genomic Health Inc. Corporate Summary
Table 49. Genomic Health Inc. Cancer Tumor Profiling Product Offerings
Table 50. Genomic Health Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 51. Hologic Gen-Probe Corporate Summary
Table 52. Hologic Gen-Probe Cancer Tumor Profiling Product Offerings
Table 53. Hologic Gen-Probe Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 54. BD Biosciences Corporate Summary
Table 55. BD Biosciences Cancer Tumor Profiling Product Offerings
Table 56. BD Biosciences Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 57. Siemens Healthineers Corporate Summary
Table 58. Siemens Healthineers Cancer Tumor Profiling Product Offerings
Table 59. Siemens Healthineers Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 60. Claris Life Sciences Corporate Summary
Table 61. Claris Life Sciences Cancer Tumor Profiling Product Offerings
Table 62. Claris Life Sciences Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 63. Personal Genome Diagnostics, Inc. Corporate Summary
Table 64. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offerings
Table 65. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 66. Perthera, Inc. Corporate Summary
Table 67. Perthera, Inc. Cancer Tumor Profiling Product Offerings
Table 68. Perthera, Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 69. Foundation Medicine, Inc Corporate Summary
Table 70. Foundation Medicine, Inc Cancer Tumor Profiling Product Offerings
Table 71. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 72. V., Strand Corporate Summary
Table 73. V., Strand Cancer Tumor Profiling Product Offerings
Table 74. V., Strand Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 75. ApoCell Corporate Summary
Table 76. ApoCell Cancer Tumor Profiling Product Offerings
Table 77. ApoCell Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 78. Contextual Genomics Corporate Summary
Table 79. Contextual Genomics Cancer Tumor Profiling Product Offerings
Table 80. Contextual Genomics Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 81. Agendia Corporate Summary
Table 82. Agendia Cancer Tumor Profiling Product Offerings
Table 83. Agendia Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 84. GenScript Corporate Summary
Table 85. GenScript Cancer Tumor Profiling Product Offerings
Table 86. GenScript Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 1. Cancer Tumor Profiling Market Opportunities & Trends in Global Market
Table 2. Cancer Tumor Profiling Market Drivers in Global Market
Table 3. Cancer Tumor Profiling Market Restraints in Global Market
Table 4. Key Players of Cancer Tumor Profiling in Global Market
Table 5. Top Cancer Tumor Profiling Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Tumor Profiling Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Tumor Profiling Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Tumor Profiling Product Type
Table 9. List of Global Tier 1 Cancer Tumor Profiling Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Tumor Profiling Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Tumor Profiling Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Tumor Profiling Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Tumor Profiling Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Tumor Profiling Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Tumor Profiling Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Tumor Profiling Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Tumor Profiling Revenue, (US$, Mn), 2023-2028
Table 30. Qiagen N.V. Corporate Summary
Table 31. Qiagen N.V. Cancer Tumor Profiling Product Offerings
Table 32. Qiagen N.V. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 33. Roche Molecular Systems Inc. Corporate Summary
Table 34. Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offerings
Table 35. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 36. Abott Molecular Corporate Summary
Table 37. Abott Molecular Cancer Tumor Profiling Product Offerings
Table 38. Abott Molecular Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 39. Illumina Inc. Corporate Summary
Table 40. Illumina Inc. Cancer Tumor Profiling Product Offerings
Table 41. Illumina Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 42. NeoGenomics Laboratories Corporate Summary
Table 43. NeoGenomics Laboratories Cancer Tumor Profiling Product Offerings
Table 44. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 45. HTG Molecular Diagnostic Corporate Summary
Table 46. HTG Molecular Diagnostic Cancer Tumor Profiling Product Offerings
Table 47. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 48. Genomic Health Inc. Corporate Summary
Table 49. Genomic Health Inc. Cancer Tumor Profiling Product Offerings
Table 50. Genomic Health Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 51. Hologic Gen-Probe Corporate Summary
Table 52. Hologic Gen-Probe Cancer Tumor Profiling Product Offerings
Table 53. Hologic Gen-Probe Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 54. BD Biosciences Corporate Summary
Table 55. BD Biosciences Cancer Tumor Profiling Product Offerings
Table 56. BD Biosciences Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 57. Siemens Healthineers Corporate Summary
Table 58. Siemens Healthineers Cancer Tumor Profiling Product Offerings
Table 59. Siemens Healthineers Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 60. Claris Life Sciences Corporate Summary
Table 61. Claris Life Sciences Cancer Tumor Profiling Product Offerings
Table 62. Claris Life Sciences Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 63. Personal Genome Diagnostics, Inc. Corporate Summary
Table 64. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offerings
Table 65. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 66. Perthera, Inc. Corporate Summary
Table 67. Perthera, Inc. Cancer Tumor Profiling Product Offerings
Table 68. Perthera, Inc. Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 69. Foundation Medicine, Inc Corporate Summary
Table 70. Foundation Medicine, Inc Cancer Tumor Profiling Product Offerings
Table 71. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 72. V., Strand Corporate Summary
Table 73. V., Strand Cancer Tumor Profiling Product Offerings
Table 74. V., Strand Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 75. ApoCell Corporate Summary
Table 76. ApoCell Cancer Tumor Profiling Product Offerings
Table 77. ApoCell Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 78. Contextual Genomics Corporate Summary
Table 79. Contextual Genomics Cancer Tumor Profiling Product Offerings
Table 80. Contextual Genomics Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 81. Agendia Corporate Summary
Table 82. Agendia Cancer Tumor Profiling Product Offerings
Table 83. Agendia Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
Table 84. GenScript Corporate Summary
Table 85. GenScript Cancer Tumor Profiling Product Offerings
Table 86. GenScript Cancer Tumor Profiling Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Cancer Tumor Profiling Segment by Type in 2021
Figure 2. Cancer Tumor Profiling Segment by Application in 2021
Figure 3. Global Cancer Tumor Profiling Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Tumor Profiling Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Tumor Profiling Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2021
Figure 8. By Type - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 12. US Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 24. China Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 37. Qiagen N.V. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abott Molecular Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Illumina Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. NeoGenomics Laboratories Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genomic Health Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hologic Gen-Probe Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BD Biosciences Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Siemens Healthineers Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Claris Life Sciences Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Perthera, Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Foundation Medicine, Inc Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. V., Strand Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. ApoCell Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Contextual Genomics Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Agendia Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. GenScript Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Cancer Tumor Profiling Segment by Type in 2021
Figure 2. Cancer Tumor Profiling Segment by Application in 2021
Figure 3. Global Cancer Tumor Profiling Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Tumor Profiling Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Tumor Profiling Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2021
Figure 8. By Type - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 12. US Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 24. China Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Tumor Profiling Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Tumor Profiling Revenue, (US$, Mn), 2017-2028
Figure 37. Qiagen N.V. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abott Molecular Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Illumina Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. NeoGenomics Laboratories Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genomic Health Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hologic Gen-Probe Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BD Biosciences Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Siemens Healthineers Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Claris Life Sciences Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Perthera, Inc. Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Foundation Medicine, Inc Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. V., Strand Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. ApoCell Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Contextual Genomics Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Agendia Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. GenScript Cancer Tumor Profiling Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
